Revvity (RVTY) Stock Price
Revvity Price
Over the last 19 years Revvity grew revenue by 3.3% annually, reaching 2.86 B USD. Earnings per share have grown at 4.5% per year over the last 19 years. For Revvity, the net margin of 8.5% is down versus 24.6% a few years ago. At today's price the dividend yield works out to roughly 0.18%. The payout ratio is around 13% of earnings. The consensus 12-month price target for Revvity is 115.00 USD, about 25.1% below where the stock trades today. Of 25 analysts, 13 rate the stock a buy — an overall Buy consensus.
Revvity stock price
Revvity business model & stock analysis
Frequently asked questions about Revvity
PerkinElmer Inc. is a company that focuses on providing products and services in the fields of diagnostics, life sciences, and applied services. Their business model revolves around offering innovative solutions for the healthcare and scientific community. With a wide range of product offerings, including instruments, reagents, consumables, software, and services, PerkinElmer Inc. aims to support scientific research, drug discovery, and diagnostics. By leveraging their expertise in detecting and analyzing biological and environmental challenges, the company strives to enable its customers to improve human and environmental health. PerkinElmer Inc.'s commitment to delivering advanced solutions makes it a trusted partner in the life sciences industry.
PerkinElmer Inc is primarily active in the scientific research and diagnostics industries.
PerkinElmer Inc faces competition from various companies in the market. Some of the main competitors of PerkinElmer Inc include Thermo Fisher Scientific Inc, Agilent Technologies Inc, Waters Corporation, and Bio-Rad Laboratories Inc. These companies also operate in the life science and analytical instrument industries, providing similar products and services. However, PerkinElmer Inc maintains a strong position in the market, leveraging its technological advancements, product innovation, and customer-centric approach to stay competitive in the industry.
PerkinElmer Inc is a highly recognized company in the field of diagnostics, life science research, and applied services. With a rich history dating back to 1937, PerkinElmer Inc has established itself as a global leader in providing innovative solutions to the scientific community. The company's commitment to improving human and environmental health is evident through its extensive range of products, technologies, and services. PerkinElmer Inc actively collaborates with research institutions, pharmaceutical companies, and government agencies to deliver cutting-edge solutions for various scientific challenges. Continuously evolving and expanding, PerkinElmer Inc remains dedicated to driving advancements and enabling breakthrough discoveries in the realms of health, safety, and environmental sustainability.
PerkinElmer Inc has accomplished several significant milestones throughout its history. With over 80 years of experience, the company has become a global leader in providing scientific solutions and technologies. Some notable achievements include the development of innovative diagnostic tools that have revolutionized healthcare, the continuous expansion of its product offering to various industries, and strategic partnerships with leading organizations. PerkinElmer Inc has also received recognition for its commitment to sustainability and social responsibility. These achievements have solidified PerkinElmer Inc's reputation as a trusted provider of high-quality scientific products and services, driving its continuous growth in the market.
PerkinElmer Inc is primarily present in various countries and regions worldwide. As a global leader in life sciences and diagnostics, PerkinElmer has a strong presence in North America, Europe, Asia Pacific, and Latin America. The company operates in over 150 countries, serving customers in academic institutions, government organizations, pharmaceutical companies, and research laboratories. With its expansive reach, PerkinElmer aims to provide innovative solutions and technologies to support advancements in human and environmental health across international borders.
PerkinElmer Inc is a leading global company that specializes in providing innovative solutions for diagnostics, life sciences, and applied services. The company aims to improve the health and well-being of people worldwide through its advanced technologies and scientific expertise. PerkinElmer Inc is committed to delivering reliable and accurate results to its customers, ensuring high-quality products and services. The company's corporate philosophy revolves around promoting sustainability, diversity, and social responsibility. With a strong focus on research and development, PerkinElmer Inc continually strives to drive technological advancements in various industries, making it a trusted leader in its field.
Analysts currently set an average price target of 110.40 USD for the Revvity stock (median: 115.00 USD), implying -28.1 % versus the latest price. The consensus is based on 25 analyst ratings.
25 analysts currently rate the Revvity stock: 13 recommend buying, 12 holding and 0 selling. For 2026, analysts expect Revvity to generate revenue of 2.85 B USD and earnings per share of 5.36 USD.
Converted at the current exchange rate, the Revvity share trades at 136.51 EUR (153.60 USD).
The Revvity share (RVTY) is listed on 7 stock exchanges, including: NYSE (PKI), London (0KHE.L), SIX (Zürich) (PKN.SW), Frankfurt (PKN.F), München (PKN.MU), Düsseldorf (PKN.DU).
PerkinElmer Inc. is an internationally operating company specializing in the provision of products and services in the fields of life sciences, diagnostics, environmental analysis, and other related markets. The company is headquartered in Waltham, Massachusetts and employs over 13,000 employees worldwide. PerkinElmer offers a wide range of products and services tailored to the needs of its customers. In the field of life sciences, PerkinElmer focuses on researching drug candidates to develop new therapeutics and diagnostic methods. The company offers a variety of instruments, software, and reagents that support laboratory analysis. Diagnostics is another important business area for PerkinElmer. In this area, the company provides products that are tailored to the needs of end consumers. This includes devices for prenatal diagnostics, in-house laboratory diagnostics, and tests in the field of genetic diseases. Another core area of PerkinElmer is environmental analysis. PerkinElmer has a long history in the development and manufacture of instruments and consumables used to identify environmental pollutants and other similar influences. The product range includes chromatography equipment, mass spectrometers, reactive chemicals, and software solutions. PerkinElmer is also active in the field of food analysis. This includes products for the identification of food allergens, analysis of nutritional aspects, and residues of pesticides and other pollutants. Another division involves supporting customers with technical support, such as installation and commissioning of instruments, application questions, and the development of test methods. PerkinElmer also offers research and development services tailored to the needs of its customers. These services include the validation of test methods, testing for the detection of pollutants, and the introduction of automation solutions in the production process. PerkinElmer has expanded its business model to fully meet the needs of its customers. The company builds on its strong expertise and history to offer high-quality products and services. Due to its wide range of products and services, PerkinElmer has expanded into several international markets. The company strives to initiate acquisitions and mergers to continuously expand its business areas. The geographical expansion efforts are primarily focused on Asian countries and other emerging markets. Thanks to its broad product range, targeted services, and international presence, PerkinElmer can make a significant contribution to meeting the requirements and needs of its customers.
The expected revenue of Revvity is 2.85 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Revvity is 607.28 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Revvity is currently 28.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Revvity stock.
The price-to-sales ratio (P/S) of Revvity is currently 6.10. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Revvity stock.
The Eulerpool Quality Score for Revvity is 0/10.
The ISIN of Revvity is US7140461093. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Revvity is 850943. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Revvity is RVTY. The ticker symbol is used to trade Revvity shares on the stock exchange.
Revvity stock
Revvity Peer Group
Revvity Ticker
Revvity FIGI
All fundamentals and in-depth analysis of Revvity
Our stock analysis for Revvity stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revvity. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.